Sunoptic Technologies has acquired LuxteL
May 2016 — Sunoptic Technologies has acquired LuxteL for an undisclosed consideration.
Sunoptic Technologies® OEM Business is focused in four major market segments: medical technology, life science, industrial/machine vision, and dental for product development and manufacturing of fiberoptic and illumination applications. Sunoptics Surgical® provides surgical headlights, Xenon and LED light sources, video cameras, documentation/recording devices, fiber optic cables and other related products. The company was founded 35 years ago and is based in Jacksonville, Florida.
LuxteL's focus in the specialty lighting industry is on a family of ceramic xenon short arc lamps, trademarked CeraLux. These products are more rugged, offer better color rendition and eliminate environmental concerns associated with other lighting techniques.
Our role in the transaction
Oaklins' team in Jacksonville advised the buyer in this transaction.
Talk to the deal team
Related deals
Life & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn moreLaboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors
Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.
Learn more